期刊
CURRENT PHARMACEUTICAL DESIGN
卷 19, 期 30, 页码 5437-5442出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612811319300014
关键词
Self-labeling tag; Site-specific labeling; SNAP-tag; antibody-based therapeutic and imaging; photoimmunotherapy; multifunctional nanocarrier
资金
- German province NRW from EFRE European Fund for Regional Development under the theme Europe - Investment in our Future
- German Academic Exchange Service (DAAD)
In the past two decades, immense advances have been achieved in the engineering, production and purifying of recombinant proteins. These proteins are being widely utilized in many fields of biology, biotechnology and medicine, including diagnostic and therapeutic applications. These applications often require the modification or conjugation of these proteins with other molecules. Researchers are spending many efforts to develop and improve the methods of protein modifications. A main challenge they face is derivatizing proteins without affecting their structure and biological function. The conjugation methods available today include random and specific chemical modifications on endogenous amino acids or carbohydrate of the protein of interest. Other methods utilize self-labeling tags as fusion partners to the original protein enabling site-specific conjugation. SNAP-tag is one of the most promising self-labeling tags, which reacts specifically, rapidly and covalently with benzylguanine (BG) derivatives. SNAP-tag fusion proteins have been successfully used for imaging living cells. Recently, several studies have utilized the SNAP technology for generating antibody-based diagnostic and therapeutic tools. We here review these approaches and their possible impact on improving cancer targeting.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据